Paras Healthcare IPO Opens Today, October 21, 2026, giving investors an opportunity to apply for shares in the hospital operator’s ₹1,450 crore public issue.
The IPO will remain open for subscription until October 23, with the price band fixed at ₹660 to ₹693 per share.
The issue is attracting attention from investors tracking India’s primary market, particularly those looking at healthcare businesses.
Before applying, investors should understand the offer structure, minimum investment, use of proceeds and the risks associated with grey market premium (GMP) estimates.
Paras Healthcare IPO Opens Today: Key Details
Paras Healthcare plans to raise ₹1,450 crore through a combination of a fresh issue worth ₹500 crore and an offer for sale (OFS) valued at ₹950 crore.
The fresh issue comprises approximately 72.15 lakh new shares, while existing shareholders Dharminder Kumar Nagar and Commelina are selling shares through the OFS.
The distinction between these two components is important. Money raised through the fresh issue goes to the company for its stated purposes, whereas proceeds from the offer for sale go to the shareholders selling their shares.
The company has appointed JM Financial, BOFA Securities India and Nuvama Wealth Management as the lead managers for the issue. MUFG Intime India is acting as the registrar.
Paras Healthcare IPO Price Band and Minimum Investment
The IPO price band is ₹660 to ₹693 per share. Retail investors must apply for a minimum of 21 shares, which translates into an investment of ₹14,553 at the upper end of the price band.
Applicants should ensure that sufficient funds are available before submitting their bids.
The minimum application amount is only one part of the decision. Investors should also examine the company’s financial performance, valuation, business risks and intended use of the money raised before deciding whether the offering suits their investment objectives.
Paras Healthcare IPO GMP Today
The grey market premium for Paras Healthcare was reported at around ₹50 per share ahead of the IPO opening.
Based on the upper price band of ₹693, this indicates an unofficial estimated listing price of approximately ₹743, although the actual listing price may be different.
GMP reflects informal trading activity before a company’s shares begin trading on the stock exchange. It is not an official exchange indicator, and its value can change with market sentiment and investor demand.
A positive premium does not guarantee listing gains or protect investors from losses.
Investors should therefore treat GMP as one market signal rather than the main reason to apply. The company’s business fundamentals and offer valuation remain important considerations.
How the IPO Proceeds Will Be Used
Of the ₹500 crore expected from the fresh issue, Paras Healthcare plans to use ₹302.9 crore to repay or prepay certain company borrowings.
Another ₹54.1 crore is earmarked for investment in its wholly owned subsidiary, Plus Medicare Hospitals Private Limited, with the remaining proceeds allocated for general corporate purposes.
The subsidiary operates a hospital in Srinagar. The planned allocation is intended to support debt repayment and investment within the company’s hospital business.
Reducing borrowings may help improve a company’s financial position, but the effect depends on its overall debt levels, operating performance and future funding requirements.
Investors should review the offer documents to understand these factors instead of relying on the proposed use of proceeds alone.
Paras Healthcare IPO Dates and Listing Schedule
The subscription window runs from October 21 to October 23, 2026. The share allotment is expected to be finalised on October 26, while refunds and credit of allotted shares are scheduled for October 27.
The shares are tentatively expected to list on the BSE and NSE on October 28, 2026.
These dates are provisional and may be subject to changes announced through official channels. Investors should check the latest issue information before applying or making decisions based on the expected listing date.
Overall, the Paras Healthcare IPO offers investors exposure to a hospital operator through the primary market. However, the issue size and reported grey market premium should not be treated as assurances of returns.
Reviewing the company’s disclosures, financial position and risk factors can help investors make a more informed decision.
